TNFSF13B and rheumatoid arthritis: In fact, the results observed in RA patients following B cell depletion therapy with rituximab suggest that alterations in the expression of B cell activating factor (BAFF)-binding receptors and an increase in class-switch recombination process, particularly in memory B cell subsets, might be associated with the re-establishment of active disease (23).